What does CUSIP 05464T104 represent in this 13F holders report?

CUSIP 05464T104 is the security identifier for AXSM - Axsome Therapeutics, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held AXSM - Axsome Therapeutics, Inc. - Common Stock in Q1 2023?

194 institutional investors reported AXSM - Axsome Therapeutics, Inc. - Common Stock for Q1 2023. Use the holders table for investor-level position and value details.

Axsome Therapeutics, Inc. - Common Stock (AXSM)

CUSIP: 05464T104

Q1 2023 13F Holders as of 31 Mar 2023

Security type / class: Equity / Common Stock
Total 13F shares: 31,901,760
Total 13F value: $1,967,140,427
Share change: +1,857,998
Put/Call ratio: 85%
SEC-reported price per share: $61.68
Number of holders: 194
Value change: +$94,141,631
Number of buys: 86
Number of sells: 103
Shares outstanding: 51,632,132

Security key

05464T104

Report period

Q1 2023

Institutions

194

Top holders

AXSM full security history Ownership snapshot Full 13F holder table Axsome Therapeutics, Inc. SEC filings Axsome Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of AXSM - Axsome Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

VANGUARD GROUP INC

Disclosed value leader

VANGUARD GROUP INC

Comparable rows

15/15

Latest evidence

31 Dec 2022

13F Lead comparable stake: 6.6% Showing 1-6 of 15 holder rows.

Quick read

VANGUARD GROUP INC leads the comparable SEC ownership view at 6.6%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens VANGUARD GROUP INC's linked filing trail.

Comparable ownership Top 5

VANGUARD GROUP INC 6.6%

RTW INVESTMENTS, LP 5.8%

BlackRock Finance, Inc. 4.8%

Fairmount Funds Management LLC 3.9%

BVF INC/IL 3.4%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
VANGUARD GROUP INC	13F Company 13F	6.6%	$263,601,648 3,417,628 shares	—	31 Dec 2022
RTW INVESTMENTS, LP	13F Company 13F	5.8%	$229,884,577 2,980,482 shares	—	31 Dec 2022
BlackRock Finance, Inc.	13F Company 13F	4.8%	$193,054,615 2,502,977 shares	—	31 Dec 2022
Fairmount Funds Management LLC	13F Company 13F	3.9%	$155,158,333 2,011,647 shares	—	31 Dec 2022
BVF INC/IL	13F Company 13F	3.4%	$135,363,150 1,755,000 shares	—	31 Dec 2022
PFM Health Sciences, LP	13F Company 13F	2.1%	$84,290,055 1,092,831 shares	—	31 Dec 2022

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

194

31,901,760

Rows available

194

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2023 vs Q1 2023 Across Filers

Q1 2023 holders

194

Q1 2023 holders

194

Holder diff

Investor	Q1 2023 Shares	Q1 2023 Shares	Share Diff	Share Chg %	Q1 2023 value	Q1 2023 value	Value change	Value Chg %